3',4'-dichlorobenzamil has been researched along with apomorphine hydrochloride, anhydrous in 1 studies
| Studies (3',4'-dichlorobenzamil) | Trials (3',4'-dichlorobenzamil) | Recent Studies (post-2010) (3',4'-dichlorobenzamil) | Studies (apomorphine hydrochloride, anhydrous) | Trials (apomorphine hydrochloride, anhydrous) | Recent Studies (post-2010) (apomorphine hydrochloride, anhydrous) |
|---|---|---|---|---|---|
| 94 | 0 | 4 | 10 | 0 | 2 |
| Protein | Taxonomy | 3',4'-dichlorobenzamil (IC50) | apomorphine hydrochloride, anhydrous (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.52 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0695 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biagini, GA; Chandramohanadas, R; Darling, C; DeGrado, WF; Diamond, SL; Fisher, N; Greenbaum, DC; Jing, H; Jo, H; Lucumi, E; Napper, AD; Shone, AE; Ward, SA | 1 |
1 other study(ies) available for 3',4'-dichlorobenzamil and apomorphine hydrochloride, anhydrous
| Article | Year |
|---|---|
Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.
Topics: Animals; Antimalarials; Drug Resistance, Multiple; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum | 2010 |